What happened
On October 5, 2026, Option Care Health, Inc. (NASDAQ: OPCH) agreed to be acquired by CD R and McKesson for $32.05 a share. The company said the deal implies an enterprise value of about $5.8 billion. CD R will hold about 51%, and McKesson will invest about $1.4 billion for the other 49%.
Option Care Health said it will stay a separate company led by its own management team. The agreement also sets a path for McKesson to later buy CD R's interest, but only if certain conditions and regulatory approvals are met. After closing, McKesson plans to account for its minority interest using the equity method.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Per-share acquisition price | $32.05 | SEC 8-K | |
| Total enterprise value | $5.8 billion | SEC 8-K | |
| CD R majority ownership interest | approximately 51% | SEC 8-K | |
| McKesson minority investment | approximately $1.4 billion | SEC 8-K | |
| Premium to October 5 close | approximately 37% | SEC 8-K |
Why it matters
The filing shifts the stock from a standalone operating case to a deal case. OptimistFi's view is that Option Care Health needs site-of-care migration to keep volume growing while reimbursement, drug mix, labor and working-capital pressure keep hurting the economics of that volume. This agreement weakens that setup by setting a fixed cash price if the deal closes.
The announced price is about 37% above Option Care Health's closing share price on October 5, 2026. McKesson's about $1.4 billion investment is about 24% of the stated enterprise value, which shows this is a shared-control structure, not a simple one-buyer sale. The main risk is still that the deal can fail if approvals or closing conditions are not met.
Browse: stock research on every company OptimistFi covers
What's next
Option Care Health expects to release third-quarter 2026 results on November 4, 2026, and it will not host a live conference call with that release. The company also withdrew its previously disclosed financial guidance. The merger still needs approval from Option Care Health stockholders and the required regulatory clearances before the expected first-half 2027 close.
If the process moves on schedule, the deal can close. If it slows or fails, the deal case weakens. If the transaction closes, Option Care Health's common stock will no longer trade on the Nasdaq Stock Exchange. That makes the approval process the next key test for investors.
More from OptimistFi
- OPCH stock: the Option Care Health thesis, its status and the next test to watch
- United States Brent Oil Fund, LP (NYSE Arca: BNO) Tracks a Supply Gap
- Alpha Teknova, Inc. (NASDAQ: TKNO) Adds Regulatory Support for PluriFreeze
- Meta Platforms, Inc. (NASDAQ: META) Has a Conditional $18 Billion Bill
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC 8-K — Current report describing the merger agreement, closing conditions and expected timing.
- SEC Exhibit 99.1 — Press release announcing the $32.05-per-share agreement, ownership split, premium and guidance withdrawal.
Read the full OptimistFi thesis on Option Care Health, Inc.: https://optimistfi.com/stocks/OPCH
See what would break the Option Care Health, Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Option Care Health, Inc. investment case, its status and the next test to watch live on the Option Care Health, Inc. thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
